What Is Semaglutide?
Semaglutide is a GLP-1 receptor agonist used as the active ingredient in prescription medicines for specific indications. Approved products, indications and access requirements vary by jurisdiction. Patients should use only a medicine prescribed and supplied through a regulated healthcare pathway.
What Is Retatrutide?
Retatrutide is an investigational agonist of GIP, GLP-1 and glucagon receptors being studied in clinical trials. It is not the same substance as semaglutide and must not be presented as an approved medicine while its safety and efficacy remain under regulatory evaluation.
Analytical Reports Are Not Medicine Approvals
A batch-specific analytical report may contain results for characteristics such as identity, concentration or purity, depending on the methods listed. It does not by itself establish sterility, clinical safety, efficacy, manufacturing compliance or regulatory approval. GenPep reports can be retrieved through the batch lookup on the homepage.
Research-Use Limitation
GenPep reference materials labelled “for research use only” are not medicines, are not substitutes for Ozempic, Wegovy or other authorised products, and are not intended for human consumption or therapeutic use. Read our research-use explanation before evaluating any material.
Authoritative Information
For information about prescribed semaglutide medicines, consult a qualified healthcare professional and the current information published by the European Medicines Agency or NHS. Clinical-trial status can change, so verify investigational compounds in an official trial registry.
Visit our homepage to explore our full range of peptides or contact us directly.